• with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product...
    90 KB (8,728 words) - 08:35, 25 April 2024
  • 8437°E / 45.727; 4.8437 Sanofi Pasteur is the vaccines division of the French multinational pharmaceutical company Sanofi. Sanofi Pasteur is the largest...
    23 KB (2,049 words) - 16:12, 16 April 2024
  • Thumbnail for Hoechst AG
    Hoechst AG (category Sanofi)
    With the new company's 2004 merger with Sanofi-Synthélabo, it became a subsidiary of the resulting Sanofi-Aventis pharmaceuticals group. The company...
    7 KB (686 words) - 03:11, 10 March 2024
  • Thumbnail for Sanofi–GSK COVID-19 vaccine
    The Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19...
    18 KB (1,385 words) - 20:42, 22 January 2024
  • Amgen Inc. v. Sanofi, 598 U.S. 594 (2023), is a United States Supreme Court case in which the Court held that Amgen's two patent applications on cholesterol-lower...
    10 KB (921 words) - 05:37, 26 February 2024
  • Thumbnail for Genzyme
    Genzyme (category Sanofi)
    innovators. In February 2022, Sanofi's new corporate brand was unveiled and former entity "Sanofi Genzyme" got integrated into Sanofi. The company was started...
    22 KB (2,013 words) - 17:35, 18 December 2023
  • Thumbnail for Valproate
    Depakin (Sanofi S.R.L. Italy) Depakine (Sanofi Aventis France) Depakine (Sanofi Synthelabo Romania) Depalept (Sanofi Aventis Israel) Deprakine (Sanofi Aventis...
    92 KB (7,947 words) - 19:43, 21 April 2024
  • Thumbnail for Sanofi–Translate Bio COVID-19 vaccine
    The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate...
    5 KB (284 words) - 12:28, 25 August 2023
  • Thumbnail for Dupilumab
    Dupilumab (category Sanofi)
    cell called eosinophils. It was developed by Regeneron Pharmaceuticals and Sanofi Genzyme. It received approval from the US Food and Drug Administration (FDA)...
    22 KB (1,841 words) - 22:50, 30 April 2024
  • – Sankyo Pharma UK Ltd Sanofi-Aventis – Sanofi-Aventis Ltd Sanofi Oasteur – Sanofi Pasteur MSD Ltd Sanofi-Synthélabo – Sanofi-Aventis Ltd Schering-Plough...
    8 KB (815 words) - 09:15, 2 April 2024
  • Thumbnail for Regeneron Pharmaceuticals
    inflammation.[citation needed] On March 26, 2012, Bloomberg announced that Sanofi and Regeneron were in development of a new drug that would help reduce cholesterol...
    26 KB (2,239 words) - 07:47, 14 April 2024
  • Thumbnail for Paul Hudson (businessman)
    Paul Hudson (businessman) (category Sanofi people)
    October 1967) is a British businessman, and the chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales...
    4 KB (230 words) - 21:03, 26 December 2023
  • 2020" (PDF). "Sanofi Form 20-F 2019" (PDF). "Sanofi Form 20-F 2018" (PDF). "Sanofi Form 20-F 2017" (PDF). "Sanofi Form 20-F 2016" (PDF). "Sanofi Form 20-F...
    61 KB (2,701 words) - 11:52, 23 April 2024
  • Thumbnail for Zentiva
    firm Advent International; it was formerly, since 2008, a subsidiary of Sanofi. The roots of the Czech pharmaceutical company date back to 1488 with At...
    9 KB (890 words) - 13:33, 10 April 2024
  • December 2022. CYD-TDV, sold under the brand name Dengvaxia and made by Sanofi Pasteur, is a live attenuated tetravalent vaccine that is administered as...
    39 KB (3,733 words) - 03:19, 31 March 2024
  • Thumbnail for Drotaverine
    Drotaverine (category Sanofi)
    No-Spa, distributed by the Hungarian plant Chinoin (owned by Sanofi). It is distributed by Sanofi as Но-Шпа (No-shpa) in Russia. Drotaverine hydrochloride...
    10 KB (795 words) - 13:04, 3 March 2024
  • Thumbnail for Team Novo Nordisk
    history 2008–2010 2011 2011–2012 2013– Team Type 1 (TT1) Team Type 1–Sanofi Aventis (TT1) Team Type 1–Sanofi (TT1) Team Novo Nordisk (TNN) Current season...
    16 KB (1,375 words) - 21:42, 16 February 2024
  • Ablynx is a subsidiary of biopharmaceutical company Sanofi engaged in the discovery and development of nanobodies, based in Science Park Zwijnaarde, Ghent...
    4 KB (335 words) - 17:13, 31 March 2024
  • Elf Sanofi (now known as Sanofi). In June 1994, Eastman Kodak sold the prescription drug business of its Sterling Winthrop subsidiary to Sanofi for US$1...
    11 KB (1,126 words) - 13:45, 9 January 2024
  • Owkin (section Sanofi)
    November 2021 through a $180 million investment from French biopharma company Sanofi. Owkin uses federated learning, a decentralized machine learning technique...
    21 KB (1,802 words) - 00:07, 22 March 2024
  • Department of Health (DOH) administered Sanofi Pasteur's Dengvaxia to schoolchildren. The program was stopped when Sanofi Pasteur advised the government that...
    27 KB (2,582 words) - 21:44, 11 February 2024
  • in the US as TriHIBit by Sanofi Pasteur, and administered by using the Sanofi DTaP vaccine Tripedia to reconstitute the Sanofi Hib vaccine ActHIB. TriHIBit...
    4 KB (207 words) - 02:18, 5 November 2023
  • allow Sanofi to combine it with insulin glargine, which was Sanofi's best selling drug at the time, with sales of around €3 billion in 2009. Sanofi planned...
    16 KB (1,438 words) - 23:07, 17 April 2024
  • Thumbnail for Insulin lispro
    approved for use in the United States in December 1999. Insulin lispro Sanofi was granted marketing authorization as a biosimilar in the European Union...
    19 KB (1,230 words) - 14:17, 18 February 2024
  • barring Regeneron and Sanofi from marketing alirocumab, which was granted in January 2017. The judge gave Regeneron and Sanofi 30 days to appeal before...
    17 KB (1,460 words) - 06:09, 7 April 2024
  • Lixisenatide (category Sanofi)
    Lyxumia in the European Union and Adlyxin in the U.S. and manufactured by Sanofi) is a once-daily injectable GLP-1 receptor agonist for the treatment of...
    21 KB (1,918 words) - 15:23, 13 April 2024
  • Thumbnail for Elias Zerhouni
    Elias Zerhouni (category Sanofi people)
    President for Global Research and Development at the pharmaceutical company Sanofi. A resident of Pasadena, Maryland, Zerhouni was born in Nedroma, Algeria...
    14 KB (1,400 words) - 22:03, 23 December 2023
  • Thumbnail for Evotec
    It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and...
    16 KB (1,301 words) - 19:18, 22 March 2024
  • Thumbnail for Irbesartan
    Irbesartan (category Sanofi)
    various brand names. It was developed by Sanofi Research (part of Sanofi-Aventis). It is jointly marketed by Sanofi-Aventis and Bristol-Myers Squibb under...
    11 KB (645 words) - 02:11, 31 March 2024
  • Thumbnail for Leflunomide
    Leflunomide (category Sanofi)
    indications that have received regulatory approval. Arava was developed by Sanofi Aventis and approved by the U.S. Food and Drug Administration in 1998. Clinical...
    22 KB (1,877 words) - 17:11, 24 February 2024